13488-22-7 Usage
Uses
Used in Pharmaceutical Industry:
5,8,11-EICOSATRIYNOIC ACID is used as a leukotriene antagonist and selective 5-LO (5-lipoxygenase) inhibitor for its anti-inflammatory properties. It helps in modulating the immune response and reducing inflammation, making it a potential candidate for the development of drugs targeting inflammatory conditions.
Used in Research and Development:
In the field of research and development, 5,8,11-EICOSATRIYNOIC ACID is used as a valuable compound for studying the structure and function of polyunsaturated fatty acids, as well as their role in various biological processes. This knowledge can contribute to the development of new therapeutic strategies and understanding the underlying mechanisms of certain diseases.
Used in Nutritional Supplements:
5,8,11-EICOSATRIYNOIC ACID may also be used as an ingredient in nutritional supplements, particularly those aimed at promoting heart health and reducing inflammation. Its presence in these supplements can provide potential health benefits to consumers, although more research is needed to fully understand its effects.
Used in Cosmetics Industry:
In the cosmetics industry, 5,8,11-EICOSATRIYNOIC ACID could be utilized for its anti-inflammatory and skin-soothing properties. It may be incorporated into skincare products to help reduce redness, inflammation, and other signs of skin irritation, providing a soothing and calming effect on the skin.
Used in Food Industry:
5,8,11-EICOSATRIYNOIC ACID may also find applications in the food industry, particularly in the development of functional foods and nutraceuticals. Its potential health benefits and anti-inflammatory properties could make it a valuable addition to products aimed at promoting overall health and well-being.
Biological Activity
5,8,11-eicosatriynoic acid is a selective inhibitor of lipoxygenases with id50 values of 24 μm and 340 μm for n-8 lipoxygenase and fatty acid cycle-oxygenase , respectively[1][2].fatty acid cycle-oxygenase and n-8 lipoxygenase catalyze the initial reactions which lead to the formation of three major arachidonic acid metabolites in human platelets. in several tissues, these two enzymes act concomitantly on arachidonic acid [1].5,8,11-eicosatriynoic acid (5,8,11-et) is a selective inhibitor of lipoxygenases with id50 values of 24 μm and 340 μm for n-8 lipoxygenase and fatty acid cycle-oxygenase, respectively. 5,8,11-eicosatriynoic acid was useful for studies on physiological and pathophysiological roles of 12 l-hydroxy-5,8,10,14-eicosatetraenoic acid formation in various tissues [1]. in mouse mastocytoma cells, 5,8,11-eicosatriynoic acid inhibited a23187 and l-cysteine induced leukotriene c (ltc4) biosynthesis with id50 value of 5 μm [2].
references
[1]. hammarstrm s. selective inhibition of platelet n-8 lipoxygenase by 5,8,11-eicosatriynoic acid. biochim biophys acta. 1977 jun 22;487(3):517-9. [2]. orning l, hammarstrm s. inhibition of leukotriene c and leukotriene d biosynthesis. j biol chem. 1980 sep 10;255(17):8023-6.
Check Digit Verification of cas no
The CAS Registry Mumber 13488-22-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,3,4,8 and 8 respectively; the second part has 2 digits, 2 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 13488-22:
(7*1)+(6*3)+(5*4)+(4*8)+(3*8)+(2*2)+(1*2)=107
107 % 10 = 7
So 13488-22-7 is a valid CAS Registry Number.
InChI:InChI=1/C20H28O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20(21)22/h2-8,11,14,17-19H2,1H3,(H,21,22)
13488-22-7Relevant articles and documents
Eicosatriynoic acid esters and amides and their application in pharmaceutical and cosmetic practice
-
, (2008/06/13)
Compound, corresponding to the formula in which R is a C1 -C8 lower alkoxy or C4 -C6 cycloalkoxy group, substituted with one or more hydroxyl groups and/or interrupted by one or more hetero atoms chosen from oxygen and sulphur, an amino group of structure STR1 in which R1 or R2, which may be identical or different, denote a hydrogen atom or a linear or branched C1 -C8 lower alkyl radical, optionally interrupted by one or more hetero atoms chosen from oxygen, sulphur and nitrogen, this alkyl radical being able to be substituted with one or more hydroxyl groups, R1 and R2 not being able to denote hydrogen simultaneously, or alternatively R1 and R2 form, together with the nitrogen atom, a heterocyclic system optionally containing oxygen, sulphur or nitrogen as an additional hetero atom, one of the radicals R1 and R2 also being able to denote, when the other is a hydrogen atom, an aryl radical of formula (II): STR2 or alternatively a benzyl radical of formula (III): STR3 in which formulae R3 and R4, denote, independently of each other, a hydrogen atom, a C1 -C4 alkyl radical, a hydroxyl group, a halogen atom or a carboxyl or trifluoromethyl group, the amine group also being able to originate from a sugar, and also the isomers and salts thereof which are pharmaceutically and cosmetically acceptable.
